Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burger

Showing results (331-340 of 338) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 338 results.
Mayo Clinic Proceedings|November 6, 2020
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort StudyZelalem Temesgen, Mariam Assi, F N U Shweta, et al.
Pulmonary Circulation|May 6, 2022
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguatFranck F Rahaghi, Vijay P Balasubramanian, Robert C Bourge, et al.
HIV Medicine|February 5, 2015
Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult lifeA Bamford, A Turkova, H Lyall, et al.
Annals of the American Thoracic Society|October 16, 2020
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association RegistryNicholas A Kolaitis, Roham T Zamanian, Vinicio A de Jesus Perez, et al.
Pulmonary Circulation|December 21, 2022
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Pulmonary Circulation|June 23, 2021
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Mayo Clinic Proceedings|March 6, 2021
Outcomes of COVID-19 With the Mayo Clinic Model of Care and ResearchJohn Charles O'Horo, James R Cerhan, Elliot J Cahn, et al.
The Lancet. Respiratory Medicine|December 12, 2018
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysisChristopher J Rhodes, Ken Batai, Marta Bleda, et al.
Pageof 34

Showing results (331-340 of 338) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 338 results.
Mayo Clinic Proceedings|November 6, 2020
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort StudyZelalem Temesgen, Mariam Assi, F N U Shweta, et al.
Pulmonary Circulation|May 6, 2022
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguatFranck F Rahaghi, Vijay P Balasubramanian, Robert C Bourge, et al.
HIV Medicine|February 5, 2015
Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult lifeA Bamford, A Turkova, H Lyall, et al.
Annals of the American Thoracic Society|October 16, 2020
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association RegistryNicholas A Kolaitis, Roham T Zamanian, Vinicio A de Jesus Perez, et al.
Pulmonary Circulation|December 21, 2022
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Pulmonary Circulation|June 23, 2021
Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association RegistryHilary M DuBrock, Charles D Burger, Sonja D Bartolome, et al.
Mayo Clinic Proceedings|March 6, 2021
Outcomes of COVID-19 With the Mayo Clinic Model of Care and ResearchJohn Charles O'Horo, James R Cerhan, Elliot J Cahn, et al.
The Lancet. Respiratory Medicine|December 12, 2018
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysisChristopher J Rhodes, Ken Batai, Marta Bleda, et al.
Pageof 34